- PharmEasy’s parent company, API Holdings, has decided not to sell Thyrocare.
- This decision is intended to reduce the company’s cash burn.
- Plans for a potential initial public offering (IPO) have been delayed until 2025.
PharmEasy Founders to Board: Not Selling Thyrocare, Will Reduce Cash Burn
- PharmEasy’s parent company, API Holdings, has decided not to sell Thyrocare.
- This decision is intended to reduce the company’s cash burn.
- Plans for a potential initial public offering (IPO) have been delayed until 2025.
[Via]
